NeoGenomics

Read more
Mark Mallon's photo - CEO of NeoGenomics

CEO

Mark Mallon

CEO Approval Rating

83/100

Founded:

2001

Status:

PublicIndependent CompanyNASDAQNEO

NEOGENOMICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Ambry Genetics is one of NeoGenomics's top competitors. Ambry Genetics was founded in 1999, and its headquarters is in Aliso Viejo, California. Like NeoGenomics, Ambry Genetics also works within the Biotechnology sector. Ambry Genetics has 600 fewer employees than NeoGenomics.

LabCorp is NeoGenomics's #2 rival. LabCorp was founded in 1905 in Burlington, North Carolina. LabCorp operates in the Biotechnology industry. LabCorp generates $14.9B more revenue than NeoGenomics.

Quest Diagnostics is a top competitor of NeoGenomics. Quest Diagnostics is a Public company that was founded in Secaucus, New Jersey in 1967. Quest Diagnostics is in the Biotechnology field. Quest Diagnostics has 47,500 more employees vs. NeoGenomics.

NeoGenomics Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$454M

NeoGenomics's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 964.4M. Over the last four quarters, NeoGenomics's revenue has grown by 32.8%. Specifically, in Q1 2021's revenue was $115.5M; in Q4 2020, it was $126M; in Q3 2020, it was $125.4M; in Q2 2020, NeoGenomics's revenue was $87M.

NeoGenomics Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Inivata Ltd.

May 2021

Source »
$390M
Inivata is a North Carolina-based biotechnology company that develops and distributes ctDNA genome-scale diagnostics tools for the treatment of cancer.
Trapelo Health

Mar 2021

Source »
$65M
Trapelo is a Massachusetts-based information technology company that provides decision-support solutions for cancer treatment and laboratories in Burlington.

-

Oncology Division, Human Longevity

Jan 2020

Source »
$37M
-
Genoptix, Inc.

Oct 2018

Source »
$125M
Genoptix is an oncology laboratory that specializes in hematology and solid tumor testing services.
Clarient Diagnostic Services. Inc.

Oct 2015

Source »
$275.2M
-

NeoGenomics Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Mar 2016
$500K
-
Equity
Mar 2009
$500K
-
IPO
Jan 2000
--
-

NeoGenomics Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Inivata is a North Carolina-based biotechnology company that develops and distributes ctDNA genome-scale diagnostics tools for the treatment of cancer.
$25M
May 25, 2020
Equity
-

NeoGenomics News

NeoGenomics Press Releases

NeoGenomics Videos

Social Media

NeoGenomics Headquarters

12701 Commonwealth Drive Suite 9

Fort Myers, Florida33913

239-768-0600

Driving Directions »

Trending Companies

NeoGenomics Summary

ABOUT

Overview

NeoGenomics is a Florida-based medical laboratory that delivers cancer diagnostics, clinical trials and related services for pharmaceutical companies in the United States. NeoGenomics was founded in 2001. NeoGenomics' headquarters is located in Fort M...

CEO

NeoGenomics's CEO, Mark Mallon, currently has an approval rating of 83%. NeoGenomics's primary competitors are Ambry Genetics, LabCorp & Quest Diagnostics.

Frequently Asked Questions about NeoGenomics

  1. When was NeoGenomics founded?

    NeoGenomics was founded in 2001
  2. Who is NeoGenomics's CEO?

    NeoGenomics's CEO is Mark Mallon
  3. How much revenue does NeoGenomics generate?

    NeoGenomics generates $454M in revenue
  4. How much funding does NeoGenomics have?

    NeoGenomics has historically raised $1M in funding
  5. Where is NeoGenomics's headquarters?

    NeoGenomics's headquarters is in Fort Myers Florida, USA
  1. How many employees does NeoGenomics have?

    NeoGenomics has 1,500 employees
  2. What sector does NeoGenomics operate in?

    NeoGenomics is in Biotechnology
  3. Who are NeoGenomics's competitors?

    NeoGenomics's top competitors are Ambry Genetics, LabCorp, Quest Diagnostics
  4. Who has NeoGenomics invested in?

    NeoGenomics's has invested in companies such as Inivata